Specify a stock or a cryptocurrency in the search bar to get a summary
Tristel
TSTLTristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom. Address: Lynx Business Park, Snailwell, United Kingdom, CB8 7NY
Analytics
WallStreet Target Price
36 300.72 GBXP/E ratio
33.0769Dividend Yield
3.05 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TSTL
Dividend Analytics TSTL
Dividend growth over 5 years
129 %Continuous growth
1 yearPayout Ratio 5 years average
136 %Dividend History TSTL
Stock Valuation TSTL
Financials TSTL
Results | 2019 | Dynamics |